Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Teva
Fuji
Farmers Insurance
Citi
Boehringer Ingelheim
Deloitte
Johnson and Johnson
Harvard Business School

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,811,731

« Back to Dashboard

Summary for Patent: 4,811,731
Title: Devices for administering medicaments to patients
Abstract:A device is provided for administering medicaments in solid finely divided form to patients. The device comprising a housing, a tray mounted in the housing and movable between first and second positions relative to the housing, a support disc provided on the tray and adapted to receive a carrier provided with at least one medicament container. A plunger is operable to penetrate a container registered therewith to open the container, movement of the tray from its first to its second position being such as to cause the support to bring a container into registration with the plunger. Air enters through an air inlet and there is an outlet through which a patient can inhale air having medicament therein.
Inventor(s): Newell; Robert E. (Pinner, GB2), Rand; Paul K. (Nitchin, GB2), Fitzsimmons; Robert A. (Barnard Castle, GB2)
Assignee: Glaxo Group Limited (London, GB2)
Application Number:06/891,536
Patent Claim Types:
see list of patent claims
Composition; Device;

Drugs Protected by US Patent 4,811,731

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,811,731

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8519141Jul 30, 1985
United Kingdom8525067Oct 10, 1985

International Patents Family Members for US Patent 4,811,731

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Hungary 199306 ➤ Subscribe
Ireland 862022 ➤ Subscribe
Ireland 59026 ➤ Subscribe
Israel 79550 ➤ Subscribe
Hungary T44182 ➤ Subscribe
Canada 1272917 ➤ Subscribe
Switzerland 672600 ➤ Subscribe
Cyprus 1481 ➤ Subscribe
Germany 3625685 ➤ Subscribe
Germany 3682457 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Queensland Health
US Army
Dow
Mallinckrodt
Fuji
McKinsey
Cipla
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot